• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.口服姜衍生的负载 siRNA 的纳米脂质体作为一种将 siRNA 药物递送至溃疡性结肠炎的有效治疗方法。
Nanomedicine (Lond). 2017 Aug;12(16):1927-1943. doi: 10.2217/nnm-2017-0196. Epub 2017 Jun 30.
2
Nanoparticles with surface antibody against CD98 and carrying CD98 small interfering RNA reduce colitis in mice.表面带有抗 CD98 抗体的纳米颗粒并携带 CD98 小干扰 RNA 可减轻小鼠结肠炎。
Gastroenterology. 2014 May;146(5):1289-300.e1-19. doi: 10.1053/j.gastro.2014.01.056. Epub 2014 Feb 4.
3
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.负载阿霉素的食用生姜衍生纳米脂质作为结肠癌治疗的新型药物递送方法
Mol Ther. 2016 Oct;24(10):1783-1796. doi: 10.1038/mt.2016.159. Epub 2016 Aug 5.
4
Functional Ginger-Derived Extracellular Vesicles-Coated ZIF-8 Containing TNF-α siRNA for Ulcerative Colitis Therapy by Modulating Gut Microbiota.功能性姜源细胞外囊泡包覆载 TNF-αsiRNA 的 ZIF-8 通过调节肠道微生物群治疗溃疡性结肠炎。
ACS Appl Mater Interfaces. 2024 Oct 9;16(40):53460-53473. doi: 10.1021/acsami.4c10562. Epub 2024 Sep 20.
5
Oral Administration of Ginger-Derived Lipid Nanoparticles and Dmt1 siRNA Potentiates the Effect of Dietary Iron Restriction and Mitigates Pre-Existing Iron Overload in KO Mice.口服姜衍生脂质纳米颗粒和 Dmt1siRNA 增强了饮食铁限制的效果,并减轻了 KO 小鼠预先存在的铁过载。
Nutrients. 2021 May 15;13(5):1686. doi: 10.3390/nu13051686.
6
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.可食用的生姜衍生纳米颗粒:预防和治疗炎症性肠病及结肠炎相关癌症的一种新型治疗方法。
Biomaterials. 2016 Sep;101:321-40. doi: 10.1016/j.biomaterials.2016.06.018. Epub 2016 Jun 9.
7
Preparation and Characterization of Ginger Lipid-derived Nanoparticles for Colon-targeted siRNA Delivery.用于结肠靶向siRNA递送的生姜脂质衍生纳米颗粒的制备与表征
Bio Protoc. 2020 Jul 20;10(14). doi: 10.21769/bioprotoc.3685.
8
Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.用载有 CD98 siRNA/PEI 的纳米颗粒靶向肠道炎症。
Mol Ther. 2014 Jan;22(1):69-80. doi: 10.1038/mt.2013.214. Epub 2013 Sep 12.
9
Oral Gavage of Ginger Nanoparticle-Derived Lipid Vectors Carrying Dmt1 siRNA Blunts Iron Loading in Murine Hereditary Hemochromatosis.口服姜纳米颗粒衍生的脂质载体携带 Dmt1siRNA 可减轻遗传性血色素沉着症小鼠的铁负荷。
Mol Ther. 2019 Mar 6;27(3):493-506. doi: 10.1016/j.ymthe.2019.01.003. Epub 2019 Jan 12.
10
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.溃疡性结肠炎的联合治疗:口服靶向纳米颗粒预防黏膜损伤并减轻炎症。
Theranostics. 2016 Sep 25;6(12):2250-2266. doi: 10.7150/thno.15710. eCollection 2016.

引用本文的文献

1
Plant-Derived Exosome-Like Nanovesicles: A Novel Strategy for Targeted Oral Therapy in Ulcerative Colitis.植物来源的外泌体样纳米囊泡:溃疡性结肠炎靶向口服治疗的新策略
Int J Nanomedicine. 2025 Sep 3;20:10595-10611. doi: 10.2147/IJN.S536056. eCollection 2025.
2
Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics.智能透皮纳米颗粒作为用于精准治疗的协同先进递送系统。
Mater Today Bio. 2025 Aug 22;34:102220. doi: 10.1016/j.mtbio.2025.102220. eCollection 2025 Oct.
3
Anion exchange chromatography-based purification of plant-derived nanovesicles from L.: molecular profiling and bioactivity in human cells.基于阴离子交换色谱法从[植物名称未给出]中纯化植物源纳米囊泡:人细胞中的分子分析与生物活性
Front Bioeng Biotechnol. 2025 Jul 31;13:1617478. doi: 10.3389/fbioe.2025.1617478. eCollection 2025.
4
Advances in plant-derived vesicle like nanoparticles-based therapies for inflammatory diseases.基于植物源类囊泡纳米颗粒的炎症性疾病治疗进展。
Asian J Pharm Sci. 2025 Aug;20(4):101052. doi: 10.1016/j.ajps.2025.101052. Epub 2025 Apr 3.
5
Plant-Derived Exosomes: Nano-Inducers of Cross-Kingdom Regulations.植物来源的外泌体:跨界调控的纳米诱导剂
Pharmaceuticals (Basel). 2025 Jul 4;18(7):1005. doi: 10.3390/ph18071005.
6
Plant-Derived Exosomes: Carriers and Cargo of Natural Bioactive Compounds: Emerging Functions and Applications in Human Health.植物源外泌体:天然生物活性化合物的载体与货物:在人类健康中的新兴功能与应用
Nanomaterials (Basel). 2025 Jun 30;15(13):1005. doi: 10.3390/nano15131005.
7
Oral Lipid Nanoparticles for Improving the Efficiency of Drug Delivery Systems in Ulcerative Colitis: Recent Advances and Future Prospects.用于提高溃疡性结肠炎药物递送系统效率的口服脂质纳米粒:最新进展与未来前景
Pharmaceutics. 2025 Apr 23;17(5):547. doi: 10.3390/pharmaceutics17050547.
8
Plant-derived vesicle-like nanoparticles in food crops: emerging insights into nutritional biofortification and biomedical applications.粮食作物中植物源囊泡状纳米颗粒:营养生物强化及生物医学应用的新见解
Plant Biotechnol J. 2025 Aug;23(8):3260-3282. doi: 10.1111/pbi.70074. Epub 2025 May 26.
9
Tolvaptan-Loaded Tomato-Derived Nanovesicles: Characterization and Evaluation of Cytotoxicity, Wound Healing Potential and the Effects on Cyst Formation in Renal Cell Lines.载有托伐普坦的番茄源纳米囊泡:肾癌细胞系中的细胞毒性、伤口愈合潜力及对囊肿形成的影响的表征与评估
Int J Nanomedicine. 2025 May 17;20:6253-6269. doi: 10.2147/IJN.S498012. eCollection 2025.
10
Plant-derived nanovesicles: Promising therapeutics and drug delivery nanoplatforms for brain disorders.植物源纳米囊泡:用于脑部疾病的有前景的治疗药物和药物递送纳米平台。
Fundam Res. 2023 Dec 5;5(2):830-850. doi: 10.1016/j.fmre.2023.09.007. eCollection 2025 Mar.

本文引用的文献

1
Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.瑞士炎症性肠病队列研究中抗TNF治疗炎症性肠病肠外表现的研究
Inflamm Bowel Dis. 2017 Jul;23(7):1174-1181. doi: 10.1097/MIB.0000000000001109.
2
Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases.炎症性肠病圆盘的开发:一种用于评估炎症性肠病残疾情况的视觉自我管理工具。
Inflamm Bowel Dis. 2017 Mar;23(3):333-340. doi: 10.1097/MIB.0000000000001033.
3
Current and emerging therapeutic targets for IBD.目前和新兴的炎症性肠病治疗靶点。
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):269-278. doi: 10.1038/nrgastro.2016.208. Epub 2017 Feb 1.
4
Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme.英夫利昔单抗生物类似药在炎症性肠病中的应用:一项管理性转换方案的结果。
J Crohns Colitis. 2017 Jun 1;11(6):690-696. doi: 10.1093/ecco-jcc/jjw216.
5
Combination Therapy for Ulcerative Colitis: Orally Targeted Nanoparticles Prevent Mucosal Damage and Relieve Inflammation.溃疡性结肠炎的联合治疗:口服靶向纳米颗粒预防黏膜损伤并减轻炎症。
Theranostics. 2016 Sep 25;6(12):2250-2266. doi: 10.7150/thno.15710. eCollection 2016.
6
Do ginger-derived nanoparticles represent an attractive treatment strategy for inflammatory bowel diseases?源自生姜的纳米颗粒是治疗炎症性肠病的一种有吸引力的策略吗?
Nanomedicine (Lond). 2016 Dec;11(23):3035-3037. doi: 10.2217/nnm-2016-0353. Epub 2016 Nov 4.
7
A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.一种用于靶向结肠癌细胞的基于透明质酸酶响应性纳米颗粒的药物递送系统。
Cancer Res. 2016 Dec 15;76(24):7208-7218. doi: 10.1158/0008-5472.CAN-16-1681. Epub 2016 Oct 14.
8
Effects of flavonol glycosides on liposome stability during freezing and drying.
Biochim Biophys Acta. 2016 Dec;1858(12):3050-3060. doi: 10.1016/j.bbamem.2016.09.020. Epub 2016 Sep 24.
9
Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.负载阿霉素的食用生姜衍生纳米脂质作为结肠癌治疗的新型药物递送方法
Mol Ther. 2016 Oct;24(10):1783-1796. doi: 10.1038/mt.2016.159. Epub 2016 Aug 5.
10
Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD).用于治疗炎症性肠病(IBD)的结肠靶向利福昔明纳米混悬液
Antiinflamm Antiallergy Agents Med Chem. 2016;15(2):101-117. doi: 10.2174/1871523015666160720103732.

口服姜衍生的负载 siRNA 的纳米脂质体作为一种将 siRNA 药物递送至溃疡性结肠炎的有效治疗方法。

Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis.

机构信息

Institute for Biomedical Sciences, Center for Diagnostics & Therapeutics, Georgia State University, Atlanta, GA 30302, USA.

Food Science & Human Nutrition Department, University of Florida, Gainesville, FL 32611, USA.

出版信息

Nanomedicine (Lond). 2017 Aug;12(16):1927-1943. doi: 10.2217/nnm-2017-0196. Epub 2017 Jun 30.

DOI:10.2217/nnm-2017-0196
PMID:28665164
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5827822/
Abstract

AIM

To develop novel siRNA delivery system overcoming the limitations of synthetic nanoparticles, such as potential side effects, nonspecificity and economic production for ulcerative colitis therapy.

MATERIALS & METHODS: Nanoparticles composed of edible ginger-derived lipid, termed ginger-derived lipid vehicles (GDLVs) were generated from ginger lipids through hydration of a lipid film, a commonly used method for a liposome fabrication. The morphology, biocompatibility and transfection efficiency of GDLVs loaded with siRNA-CD98 (siRNA-CD98/GDLVs) were characterized by standard methods.

RESULTS

Orally administered siRNA-CD98/GDLVs were effectively targeted specifically to colon tissues, resulting in reduced expression of CD98.

CONCLUSION

These GDLVs have great promise as efficient siRNA-delivery vehicles while potentially obviating issues related to the traditional synthetic nanoparticles. As such, they help shift the current paradigm of siRNA delivery away from artificially synthesized nanoparticles toward the use of naturally derived nanovehicles from edible plants.

摘要

目的

开发克服合成纳米颗粒局限性的新型 siRNA 递药系统,例如用于溃疡性结肠炎治疗的潜在副作用、非特异性和经济生产。

材料与方法

通过水合脂质膜从姜脂中生成由可食用姜衍生脂质组成的纳米颗粒,即姜衍生脂质载体(GDLV),这是一种常用于脂质体制备的方法。通过标准方法对负载 siRNA-CD98 的 GDLV(siRNA-CD98/GDLV)进行形态、生物相容性和转染效率的表征。

结果

经口服给予的 siRNA-CD98/GDLV 可特异性靶向结肠组织,从而降低 CD98 的表达。

结论

这些 GDLV 有望成为高效的 siRNA 递药载体,同时可能避免与传统合成纳米颗粒相关的问题。因此,它们有助于将 siRNA 递药的当前范式从人工合成纳米颗粒转向使用来自食用植物的天然衍生纳米载体。